Theragen Etex Statistics

Total Valuation

Theragen Etex has a market cap or net worth of KRW 104.73 billion. The enterprise value is 130.65 billion.

Market Cap	104.73B
Enterprise Value	130.65B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Theragen Etex has 36.68 million shares outstanding. The number of shares has increased by 26.35% in one year.

Current Share Class	36.68M
Shares Outstanding	36.68M
Shares Change (YoY)	+26.35%
Shares Change (QoQ)	+1.98%
Owned by Insiders (%)	27.43%
Owned by Institutions (%)	0.87%
Float	24.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.39
PB Ratio	0.72
P/TBV Ratio	0.88
P/FCF Ratio	59.37
P/OCF Ratio	17.40
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.86, with an EV/FCF ratio of 74.06.

EV / Earnings	-2.81
EV / Sales	0.49
EV / EBITDA	7.86
EV / EBIT	12.85
EV / FCF	74.06

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 0.29.

Current Ratio	1.52
Quick Ratio	1.12
Debt / Equity	0.29
Debt / EBITDA	3.04
Debt / FCF	24.13
Interest Coverage	2.96

Financial Efficiency

Return on equity (ROE) is -26.86% and return on invested capital (ROIC) is 2.23%.

Return on Equity (ROE)	-26.86%
Return on Assets (ROA)	1.74%
Return on Invested Capital (ROIC)	2.23%
Return on Capital Employed (ROCE)	4.96%
Revenue Per Employee	1.20B
Profits Per Employee	-207.36M
Employee Count	224
Asset Turnover	0.99
Inventory Turnover	3.90

Taxes

Income Tax	-5.23B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.65% in the last 52 weeks. The beta is 0.18, so Theragen Etex's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	-9.65%
50-Day Moving Average	2,675.00
200-Day Moving Average	2,919.45
Relative Strength Index (RSI)	68.13
Average Volume (20 Days)	103,273

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Theragen Etex had revenue of KRW 268.13 billion and -46.45 billion in losses. Loss per share was -1,255.32.

Revenue	268.13B
Gross Profit	138.23B
Operating Income	7.55B
Pretax Income	-49.50B
Net Income	-46.45B
EBITDA	14.00B
EBIT	7.55B
Loss Per Share	-1,255.32

Full Income Statement

Balance Sheet

The company has 36.27 billion in cash and 42.57 billion in debt, giving a net cash position of -6.29 billion or -171.58 per share.

Cash & Cash Equivalents	36.27B
Total Debt	42.57B
Net Cash	-6.29B
Net Cash Per Share	-171.58
Equity (Book Value)	145.00B
Book Value Per Share	3,532.68
Working Capital	48.77B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.02 billion and capital expenditures -4.25 billion, giving a free cash flow of 1.76 billion.

Operating Cash Flow	6.02B
Capital Expenditures	-4.25B
Free Cash Flow	1.76B
FCF Per Share	48.09

Full Cash Flow Statement

Margins

Gross margin is 51.55%, with operating and profit margins of 2.81% and -17.32%.

Gross Margin	51.55%
Operating Margin	2.81%
Pretax Margin	-18.46%
Profit Margin	-17.32%
EBITDA Margin	5.22%
EBIT Margin	2.81%
FCF Margin	0.66%

Dividends & Yields

Theragen Etex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.35%
Shareholder Yield	-26.35%
Earnings Yield	-44.35%
FCF Yield	1.68%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Theragen Etex has an Altman Z-Score of 2.01 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.01
Piotroski F-Score	6